Historical salary details - Mr. Daniel G. Welch, Chairman of the Board, Structure Therapeutics Inc - ADR
Mr. Daniel G. Welch is the Chairman of the Board of Structure Therapeutics Inc - ADR. They also hold 3 other positions in Ultragenyx Pharmaceutical Inc., Nuvation Bio Inc - Ordinary Shares - Class A and Prothena Corporation plc.
Mr. Daniel G. Welch
Chairman of the Board
-
Gross Remuneration
-
Current Company
Structure Therapeutics Inc - ADR
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Structure Therapeutics Inc - ADR | Chairman of the Board | - | - |
| 2024 | Ultragenyx Pharmaceutical Inc. | Chairman of the Board | - | - |
| 2024 | Nuvation Bio Inc - Ordinary Shares - Class A | Chairman of the Board | - | - |
| 2024 | Prothena Corporation plc | Chairman of the Board | - | - |
| 2023 | Ultragenyx Pharmaceutical Inc. | Chairman of the Board | 499.9 K | 0.1 % |
| 2023 | Nuvation Bio Inc - Ordinary Shares - Class A | Chairman of the Board | 484.8 K | 467.0 % |
| 2023 | Prothena Corporation plc | Independent Director | - | - |
| 2023 | Structure Therapeutics Inc - ADR | Chairman of the Board | - | - |
| 2022 | Structure Therapeutics Inc - ADR | Chairman of the Board | 2.4 M | 982.2 % |
| 2022 | Ultragenyx Pharmaceutical Inc. | Chairman of the Board | 499.4 K | 0.1 % |
| 2022 | Seagen Inc | Independent Director | 468.5 K | - |
| 2022 | Nuvation Bio Inc - Ordinary Shares - Class A | - | 85.5 K | -77.3 % |
| 2022 | Nuvation Bio Inc - Warrants (07/07/2027) | Chairman of the Board | 85.5 K | - |
| 2021 | Ultragenyx Pharmaceutical Inc. | Chairman of the Board | 498.9 K | 8.2 % |
| 2021 | Nuvation Bio Inc - Ordinary Shares - Class A | Chairman of the Board | 376.6 K | - |
| 2021 | Structure Therapeutics Inc - ADR | Chairman of the Board | 224 K | - |
| 2020 | Ultragenyx Pharmaceutical Inc. | Chairman of the Board | 461.1 K | 7.1 % |
| 2019 | Ultragenyx Pharmaceutical Inc. | Chairman of the Board | 430.4 K | -23.6 % |
| 2018 | Ultragenyx Pharmaceutical Inc. | Chairman of the Board | 563.2 K | 57.1 % |
| 2017 | Ultragenyx Pharmaceutical Inc. | Chairman of the Board | 358.6 K | 3.2 % |
| 2016 | Ultragenyx Pharmaceutical Inc. | Chairman of the Board | 347.6 K | -67.0 % |
| 2015 | Ultragenyx Pharmaceutical Inc. | Chairman of the Board | 1.1 M | - |